跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
全可利 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Bosentan Dispersible Tablets
Approved
化学药品
Bosentan Dispersible Tablets
Janssen-Cilag AG
🇨🇳 National Medical Products Administration
Approval Date
Sep 5, 2019
Approval ID
7uctHdGo5Lh
Company
Janssen-Cilag AG
Type
化学药品
Approval Details
Approval Id
7uctHdGo5Lh
Approval Number
H20190051
Generic Name
波生坦分散片
Generic Name En
Bosentan Dispersible Tablets
Trade Name
全可利
Brand Name
全可利
Drug Type
化学药品
Dosage Form
片剂
Strength
32mg(以C₂₇H₂₉N₅O₆S计)
Reg Date
2019-09-05
Expired Date
2024-09-04
Company Name
Janssen-Cilag AG
Company Address
Gubelstrasse 34,6300 Zug, Switzerland
Production Company Name
Patheon Inc
Production Company Address
2100 Syntex Court, Mississauga, Ontario, L5N7K9, Canada
Company Detail Path
/organization/janssen-cilag-ag
Production Company Detail Path
/organization/patheon-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 5, 2019
Approval ID
7uctHdGo5Lh
Type
化学药品
Back to NMPA Approvals